Tianma Medical Group

About:

Suzhou Tianma Medical Group is a large-scale enterprise focused on fine chemicals, biological pharmacy, and tourism real estate.

Website: http://www.tianmapharma.com/

Top Investors: Shenzhen Capital Group

Description:

Suzhou Tianma Medical Group (天马精化) is a large-scale technology enterprise integrating industries of fine chemicals, and biological pharmacy with tourism real estate. It has positively implemented the policy of industrialization, standardization, market, and scale and has been dedicated to constructing an enterprise group with interactive development between capital operations and industrial operations. Through incremental investment, it takes the initiative to look for industrial expansion. With the introduction and innovation of technologies, Suzhou Tianma Medical Group has evolved from traditional pharmaceutical intermediates and ingredients to full preparation and has become the key vendor for plenty of domestic crude drugs. In 2010, Suzhou Tianma Fine Chemicals Co., Ltd. which is under the group company, was officially listed in Shenzhen Stock Exchange. Its products cover four major fields, including fine chemicals, advanced pharmaceutical intermediates, pharmaceutical ingredients, paper-making chemicals, and more.

Total Funding Amount:

118M CNY

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

1993-01-01

Contact Email:

info(AT)tianmachem.com

Founders:

Number of Employees:

1001-5000

Last Funding Date:

2013-06-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai